Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/17/2013
Last 10 Quotes:
What's This?
Earnings vs. Expectations
Compare| Jun 2012* | Sep 2012* | Dec 2012* | Mar 2013* | Jun 2013* | |
| * Quarter Ending | |||||
|---|---|---|---|---|---|
| Estimated EPS($) | 0.84 | 0.90 | 1.00 | 0.77 | 0.84 |
| Reported EPS($) | NA | NA | NA | NA | NA |
| GAAP($) | 0.25 | 0.23 | NA | 0.20 | NA |
| Jun 2013* | Sep 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
| Average Estimate ($) | 0.84 | 0.86 | 3.61 | 3.92 |
| Number of Analysts | 5 | 5 | 26 | 25 |
| Low Estimate ($) | 0.74 | 0.75 | 3.46 | 3.42 |
| High Estimate ($) | 0.88 | 0.93 | 4.01 | 4.40 |
| Jun 2013* | Sep 2013* | Dec 2013** | Dec 2014** | |
| * Quarter Ending ** Fiscal Year Ending | ||||
|---|---|---|---|---|
| Current Estimate ($) | 0.84 | 0.86 | 3.61 | 3.92 |
| 30 Days Ago ($) | 0.85 | 0.88 | 3.55 | 3.85 |
| 90 Days Ago ($) | 0.86 | 0.88 | 3.64 | 3.94 |
| Dec 2013* | Dec 2014* | Next 3 Years (per year) | Forward P/E | PEG | ||
| * Year Ending | ||||||
|---|---|---|---|---|---|---|
| GSK | 1.50% | 0.28% | 5.48% | 14.73 | 1.83 | |
